Back to News
investment

Vet Firm IVC Evidensia Scraps $5.5 Billion Leveraged-Loan Deal

Jeannine Amodeo
Loading...
1 min read
0 likes
⚡ Quantum Brief
Europe’s largest veterinary services provider abandoned a $5.5 billion leveraged-loan deal, marking another high-profile collapse in the syndicated debt market this year. The transaction, led by Goldman Sachs, was pulled just weeks after launch due to insufficient lender demand, according to insiders familiar with the matter. This follows a broader trend of stalled leveraged loan deals in 2026, reflecting tightening credit conditions and investor caution amid economic uncertainty. The withdrawn financing was intended to extend existing debt, highlighting challenges in refinancing large corporate borrowings in the current market environment. The move underscores growing volatility in debt markets, with lenders increasingly reluctant to underwrite high-risk, high-value transactions.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (35).png
Quantum News · Media Library

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Europe’s largest veterinary services provider, IVC Evidensia Ltd., has shelved a plan to extendBloomberg Terminal about $5.5 billion of debt, adding to a number of stalled leveraged loan deals this year.A group of lenders led by Goldman Sachs Group Inc. launched the deal earlier this month, but withdrew the transaction from the syndicated market, according to people familiar with the matter, who asked not to be identified because they’re not authorized to speak publicly.

Read Original

Source Information

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.